MedPath

Sitaglinex

Brand Name: Sitaglinex

Generic Name: Sitagliptin (as phosphate)

Active
Registration Number

DRP-12317

Dosage Form

Film-Coated Tablet

Issuance Date

July 14, 2022

Expiry Date

July 14, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Sitagliptin (as phosphate)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform